Trastuzumab re-treatment following adjuvant trastuzumab and the importance of distant disease-free interval: the HERA trial experience

HREA Study Team, Otto Metzger-Filho, Evandro de Azambuja, Marion Procter, Magalie Krieguer, Ian Smith, Jose Baselga, David Cameron, Michael Untch, Christian Jackisch, Richard Bell, Luca Gianni, Aron Goldhirsch, Martine Piccart, Richard D Gelber

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Trastuzumab re-treatment following adjuvant trastuzumab and the importance of distant disease-free interval: the HERA trial experience'. Together they form a unique fingerprint.

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Immunology and Microbiology